An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer
Clinical trial NCT01658878 · COMPLETED
Trial details
- NCT number
- NCT01658878
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-30
- Primary completion
- 2024-11-12
- Enrollment
- 657
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.